Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Avanos Medical Inc.

    NYSE: AVNS · Real-Time Price · USD
    12.10
    -0.27 (-2.18%)
    At close: Jun 13, 2025, 3:59 PM
    12.05
    -0.41%
    After-hours: Jun 13, 2025, 04:09 PM EDT

    Avanos Medical Statistics

    Share Statistics

    Avanos Medical has 46.24M shares outstanding. The number of shares has increased by 0.22% in one year.

    Shares Outstanding

    n/a
    		 46.24M

    Shares Change (YoY)

    n/a
    		 0.22%

    Shares Change (QoQ)

    n/a
    		 0.1%

    Owned by Institutions (%)

    n/a
    		 93.82%

    Shares Floating

    n/a
    		 44.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 756

    FTD / Avg. Volume

    n/a
    		 0.15%

    Short Selling Information

    The latest short interest is 1.56M, so 3.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.56M

    Short % of Shares Out

    n/a
    		 3.39%

    Short % of Float

    n/a
    		 4.83%

    Short Ratio (days to cover)

    n/a
    		 3.63

    Valuation Ratios

    The PE ratio is -1.87 and the forward PE ratio is 11.2. Avanos Medical's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.87

    Forward PE

    n/a
    		 11.2

    PS Ratio

    n/a
    		 1.06

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 0.88

    P/FCF Ratio

    n/a
    		 8.83

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Avanos Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.21.

    Current Ratio

    n/a
    		 2.37

    Quick Ratio

    n/a
    		 1.53

    Debt / Equity

    n/a
    		 0.21

    Debt / EBITDA

    n/a
    		 -0.49

    Debt / FCF

    n/a
    		 2.05

    Interest Coverage

    n/a
    		 -32.48

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $308,845.98

    Profits Per Employee

    n/a
    		 $-176,066.46

    Employee Count

    n/a
    		 2,227

    Asset Turnover

    n/a
    		 0.6

    Inventory Turnover

    n/a
    		 2.21

    Taxes

    Income Tax

    n/a
    		 -17M

    Effective Tax Rate

    n/a
    		 4.22%

    Stock Price Statistics

    The stock price has increased by -37.17% in the last 52 weeks. The beta is 1.14, so Avanos Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.14

    52-Week Price Change

    n/a
    		 -37.17%

    50-Day Moving Average

    n/a
    		 12.63

    200-Day Moving Average

    n/a
    		 17.24

    Relative Strength Index (RSI)

    n/a
    		 46.52

    Average Volume (20 Days)

    n/a
    		 493,552

    Income Statement

    In the last 12 months, Avanos Medical had revenue of 687.8M and earned -392.1M in profits. Earnings per share was -8.53.

    Revenue

    n/a
    		 687.8M

    Gross Profit

    n/a
    		 381.3M

    Operating Income

    n/a
    		 -396.2M

    Net Income

    n/a
    		 -392.1M

    EBITDA

    n/a
    		 -345.6M

    EBIT

    n/a
    		 -391.1M

    Earnings Per Share (EPS)

    n/a
    		 -8.53
    Full Income Statement

    Balance Sheet

    The company has 107.7M in cash and 170.2M in debt, giving a net cash position of -62.5M.

    Cash & Cash Equivalents

    n/a
    		 107.7M

    Total Debt

    n/a
    		 170.2M

    Net Cash

    n/a
    		 -62.5M

    Retained Earnings

    n/a
    		 -707M

    Total Assets

    n/a
    		 1.11B

    Working Capital

    n/a
    		 215.2M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 100.7M and capital expenditures -17.8M, giving a free cash flow of 82.9M.

    Operating Cash Flow

    n/a
    		 100.7M

    Capital Expenditures

    n/a
    		 -17.8M

    Free Cash Flow

    n/a
    		 82.9M

    FCF Per Share

    n/a
    		 1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 55.44%, with operating and profit margins of -57.6% and -57.01%.

    Gross Margin

    n/a
    		 55.44%

    Operating Margin

    n/a
    		 -57.6%

    Pretax Margin

    n/a
    		 -58.64%

    Profit Margin

    n/a
    		 -57.01%

    EBITDA Margin

    n/a
    		 -50.25%

    EBIT Margin

    n/a
    		 -57.6%

    FCF Margin

    n/a
    		 12.05%

    Dividends & Yields

    AVNS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AVNS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.12

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist